...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours.
【24h】

Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours.

机译:基于剂量和生物学模型的螺旋肿瘤疗法与(反向计划)IMAT对前列腺肿瘤的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Helical tomotherapy (HT) and intensity-modulated arc therapy (IMAT) are two arc-based approaches to the delivery of intensity-modulated radiotherapy (IMRT). Through plan comparisons we have investigated the potential of IMAT, both with constant (conventional or IMAT-C) and variable (non-conventional or IMAT-NC, a theoretical exercise) dose-rate, to serve as an alternative to helical tomotherapy. MATERIALS AND METHODS: Six patients with prostate tumours treated by HT with a moderately hypo-fractionated protocol, involving a simultaneous integrated boost, were re-planned as IMAT treatments. A method for IMAT inverse-planning using a commercial module for static IMRT combined with a multi-leaf collimator (MLC) arc-sequencing was developed. IMAT plans were compared to HT plans in terms of dose statistics and radiobiological indices. RESULTS: Concerning the planning target volume (PTV), the mean doses for all PTVs were similar for HT and IMAT-C plans with minimum dose, target coverage, equivalent uniform dose (EUD) and tumour control probability (TCP) values being generally higher for HT; maximum dose and degree of heterogeneity were instead higher for IMAT-C. In relation to organs at risk, mean doses and normal tissue complication probability (NTCP) values were similar between the two modalities, except for the penile bulb where IMAT was significantly better. Re-normalizing all plans to the same rectal toxicity (NTCP=5%), the HT modality yielded higher TCP than IMAT-C but there was no significant difference between HT and IMAT-NC. The integral dose with HT was higher than that for IMAT. CONCLUSIONS: with regards to the plan analysis, the HT is superior to IMAT-C in terms of target coverage and dose homogeneity within the PTV. Introducing dose-rate variation during arc-rotation, not deliverable with current linac technology, the simulations result in comparable plan indices between (IMAT-NC) and HT.
机译:背景与目的:螺旋断层扫描(HT)和强度调制弧光治疗(IMAT)是两种基于弧线的方法来进行强度调制放射治疗(IMRT)。通过计划比较,我们研究了恒定剂量(常规或IMAT-C)和可变剂量(非常规或IMAT-NC,一种理论研究)的IMAT替代螺旋断层扫描的潜力。材料与方法:将6例经HT治疗的前列腺癌患者,以中等程度的低分割方案治疗,包括同时进行的综合增强治疗,被重新规划为IMAT治疗。开发了一种使用商用模块进行静态IMRT并结合多叶准直仪(MLC)电弧排序的IMAT逆计划方法。在剂量统计和放射生物学指标方面,将IMAT计划与HT计划进行了比较。结果:关于计划目标量(PTV),HT和IMAT-C计划的所有PTV的平均剂量均相似,且最低剂量,目标覆盖率,等效均等剂量(EUD)和肿瘤控制概率(TCP)值通常较高对于HT;相反,IMAT-C的最大剂量和异质性程度更高。关于有风险的器官,两种方式之间的平均剂量和正常组织并发症发生率(NTCP)值相似,除了阴茎鳞茎的IMAT明显好于其他。将所有计划重新标准化为相同的直肠毒性(NTCP = 5%),HT方式产生的TCP比IMAT-C高,但是HT和IMAT-NC之间没有显着差异。 HT的积分剂量高于IMAT的积分剂量。结论:就计划分析而言,HT在PTV内的靶标覆盖率和剂量均一性方面优于IMAT-C。引入了电弧旋转过程中的剂量率变化,这是当前的直线加速器技术无法实现的,模拟结果得出了(IMAT-NC)和HT之间可比的计划指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号